Skip to main content

Month: April 2020

Valmet to deliver a biomass-fired boiler plant to Tampereen Sähkölaitos in Tampere, Finland

Valmet Oyj’s press release on April 24, 2020 at 11:00 a.m. EETValmet will deliver a biomass-fired boiler plant to Tampereen Sähkölaitos Oy’s Naistenlahti power plant in Tampere, Finland. The new Naistenlahti 3 boiler will replace the Naistenlahti 2 boiler that has reached the end of its technical lifetime.The order is included in Valmet’s orders received of the second quarter 2020. The value of the order is approximately EUR 70 million. The boiler plant will be handed over to the customer at the end of the year 2022.“Tampereen Sähkölaitos took a turn towards sustainable energy production in 2010 and started to systematically use more and more renewable energy sources and lower its CO2 emissions. Our goal is a 95 percent decrease in emissions by the end of 2030. Thanks to the Naistenlahti 3 boiler plant, our CO2 emissions will reduce significantly,...

Continue reading

Valmet toimittaa uusiutuvia biomassoja käyttävän kattilalaitoksen Tampereen Sähkölaitokselle

Valmet Oyj:n lehdistötiedote 24.4.2020 klo 11.00Valmet toimittaa uusiutuvia biomassoja käyttävän kattilalaitoksen Tampereen Sähkölaitos Oy:n Naistenlahden voimalaitokselle. Uusi Naistenlahti 3 -kattila korvaa Naistenlahti 2 -kattilan, joka on tullut teknisen käyttöikänsä päähän.Tilaus sisältyy Valmetin vuoden 2020 toisen vuosineljänneksen saatuihin tilauksiin. Tilauksen arvo on noin 70 miljoonaa euroa. Kattilalaitos luovutetaan asiakkaalle vuoden 2022 lopulla.”Tampereen Sähkölaitos teki vuonna 2010 energiakäänteen ja alkoi systemaattisesti siirtyä käyttämään yhä enemmän uusiutuvia energialähteitä ja vähentämään hiilidioksidipäästöjä. Tavoitteena on 95 prosentin päästövähennys vuoden 2030 loppuun mennessä. Naistenlahti 3:n ansiosta hiilidioksidipäästömme tulevat laskemaan merkittävästi ja uusiutuvien energialähteiden osuus nousee”, sanoo...

Continue reading

Correction: Taaleri Plc: Notice to the Annual General Meeting 18 May 2020

TAALERI PLC’S STOCK EXCHANGE RELEASE 24 APRIL 2020 AT 11.00 A.M. (EET)Correction to TAALERI PLC: NOTICE TO THE ANNUAL GENERAL MEETING 18 MAY 2020 published 24 April 2020 at 10.00 Corrected sentence: The Board of Directors proposes that a dividend of EUR 0.16 per share be paid based on the balance sheet adopted for the financial year ended 31 December 2019. The dividend will be paid to shareholders who on the dividend record date of 20 May 2020 are entered as shareholders in the company’s shareholder register held by Euroclear Finland Ltd. The Board of Directors proposes that the dividend be paid on 28 May 2020.Below the corrected release:NOTICE TO THE ANNUAL GENERAL MEETINGDate                   Monday, 18 May 2020 at 10.00 a.m.Place                  Taaleri Plc’s headquarters, Kasarmikatu 21 B, 00130 Helsinki, FinlandThe shareholders...

Continue reading

Bijeenroeping gewone algemene vergadering van woensdag 27 mei 2020 om 11 uur

Naamloze VennootschapNijverheidsstraat 2, 2340 BeerseBTW BE0403.807.337 – RPR TurnhoutBelangrijke voorafgaandelijke mededeling aan de aandeelhoudersGelet op het koninklijk besluit nr. 4 van 9 april 2020 inzake de strijd tegen de COVID-19-pandemie is het de aandeelhouders en personen met het recht om deel te nemen aan de algemene vergadering of hun volmachthouders verboden om fysiek aanwezig te zijn op de algemene vergadering.De vennootschap voorziet de mogelijkheid voor de aandeelhouders om de algemene vergadering bij te wonen via elektronisch communicatie (Zoom Video Call). De aandeelhouders worden daarom verzocht hun e-mail te vermelden bij hun registratie voor deelname. Bovendien krijgen de aandeelhouders – volgens de modaliteiten hieronder vermeld – de mogelijkheid op voorhand vragen schriftelijk te stellen alsook op voorhand...

Continue reading

Investeringsforeningen Investin – Ændring af spreads

Midlertidig ændring af emissions- og indløsningssatser justeres tilbage til normal satserPortefølje Administration A/S monitorerer løbende aktuelle markedsforhold og har vurderet, at de midlertidige ændringer af emissions- og indløsningssatser for nedenstående afdeling justeres tilbage til normaliserede satser. Nykredit Portefølje Administration A/S monitorerer fortsat løbende aktuelle markedsforhold. Afdelingerne og %-satserne er angivet nedenfor:Eventuelle spørgsmål vedrørende denne meddelelse kan rettes til adm. direktør Martin Udbye Madsen, tlf. 44 55 86 45.Med venlig hilsenNykredit Portefølje Administration A/SMartin Udbye Madsen, adm. direktørVedhæftet filFondbørsmeddelelse – Ændring af spreads – 23. april 2020 – Investin

Continue reading

Investeringsforeningen Multi Manager Invest – Ændring af spreads

Midlertidig ændring af emissions- og indløsningssatserNykredit Portefølje Administration A/S har foretaget en midlertidig ændring af i forvejen forhøjet emissions- og indløsningssatser, således at emissions- og indløsningssatserne nedsættes for afdelinger i nedenstående tabel. Nykredit Portefølje Administration A/S monitorerer løbende aktuellemarkedsforhold og har vurderet, at de nuværende markedsforhold giver anledning til at justere emissionstillæg og indløsningsfradrag. Afdelingerne og %-satserne er angivet nedenfor:Når der igen vendes tilbage til emissions- og indløsningssatsers i henhold til prospektet vil der blive meddelelse herom.Eventuelle spørgsmål vedrørende denne meddelelse kan rettes til adm. direktør Martin Udbye Madsen, tlf. 44 55 86 45.Med venlig hilsenNykredit Portefølje Administration A/SMartin Udbye Madsen, adm. direktørVedhæftet...

Continue reading

WPD Pharmaceuticals Announces FDA Application Under The Orphan Drug Act Was Submitted By License Partner for Brain Cancer Drug, Berubicin

VANCOUVER, British Columbia, April 24, 2020 (GLOBE NEWSWIRE) — WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical stage pharmaceutical company is pleased to announced that its license partner, CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS“) filed an application with the U.S. Food and Drug Administration (“FDA”) under the Orphan Drug Act to receive Orphan Drug Designation (“ODD”) for its brain cancer drug candidate, Berubicin. WPD was previously awarded a reimbursement grant of approximately $6 million by the Polish National Center for Research and Development for a Phase 2 study of Berubicin, in Poland.Under a prior developer, Berubicin, then known as RTA 744, was granted ODD by the FDA for the treatment of malignant gliomas. In the prior developer’s Phase 1 trial of Berubicin,...

Continue reading

AgraFlora Organics Completes First Batch of CBD Oil and CBD Distillate

VANCOUVER, British Columbia, April 24, 2020 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc.  (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) is pleased to announce its wholly owned subsidiary Sustainable Growth Strategic Capital Corp. (“SGSC” or “the Company”) a federally licensed cannabis company based in the Greater Toronto Area (“GTA”) has successfully produced the first full run of full spectrum winterized CBD crude oil (“CBD Oil”) and CBD distillate.SGSC is focused on taking advantage of the underserviced market for CBD Oil, CBD Distillate and CBD Isolate by crafting partnerships to generate revenue while limiting fiscal and operational risk. SGSC has previously partnered with Micro C45 Inc. (“MC45”), a Canadian company that has developed a unique post-harvest mechanical separation process...

Continue reading

SCANFIL JATKAA OMIEN OSAKKEIDEN HANKINTAA

SCANFIL OYJ      PÖRSSITIEDOTE    24.4.2020     KLO 9.45Hallituksen päätöksen perusteella omien osakkeiden hankinta päättyy viimeistään seuraavaan varsinaiseen yhtiökokoukseen, kuitenkin viimeistään 30. kesäkuuta 2021. Omia osakkeita voidaan hankkia ohjelman puitteissa vielä yhteensä 145 309 kappaletta. Osakkeiden hankintaan käytetään yhteensä enintään 1,4 miljoonaa euroa. Osakkeet hankitaan Nasdaq Helsinki Oy:n julkisessa kaupankäynnissä hankintahetken markkinahintaan.  Hankittavia osakkeita käytetään yhtiön avainhenkilöiden optio-ohjelmiin liittyvien velvoitteiden täyttämiseksi.Yhtiön hallitus päätti 9.3.2020 käyttää varsinaisen yhtiökokouksen 24.4.2019 antamaa valtuutusta hankkia omia osakkeita. Hankittavien osakkeiden yhteismäärä oli enintään 300 000 osaketta mikä vastaa noin 0,5 % osakkeiden kokonaismäärästä. Hallituksen päätöksen...

Continue reading

SCANFIL CONTINUES TO REPURCHASE OWN SHARES  

SCANFIL PLC     STOCK EXCHANGE RELEASE   24 APRIL  2020      9.45 A.M.Scanfil Oyj’s Board of Directors has today, on 24 April 2020 decided to continue to repurchase the Company’s own shares based on the authorization given by the Annual General Meeting held on 23 April 2020. The repurchases are part of the share repurchase program initiated on 9 March 2020.Based on the decision made by the Board of Directors, the repurchasing of shares will end by the next Annual General Meeting at the latest, however no later than 30 June 2021. As part of the share repurchaseprogram a total of 145,309 shares can still be repurchased. The maximum amount of euros to be used for the repurchase is total EUR 1.4 million. The shares will be repurchased in public trading on the Nasdaq Helsinki Ltd at the market price prevailing at the time of repurchase. The...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.